When Breakthrough Falls Short: US FDA Complete Response Letters Rising Among BTD Applications For Approval

 
• By Bridget Silverman
Breakthrough designations have allowed many therapies to climb quickly through development and review, but more are falling short of approval and getting complete response letters. • Source: Alamy

More from Product Reviews

More from Pink Sheet